后COVID-19刺激性肠综合征:一个综合性审查
Julyanne Tereza Cordeiro Silva1, Olival Cirilo Lucena da Fonseca Neto2
1Centro Universitário Maurício de Nassau, Recife - PE - Brasil.
Revista do Colegio Brasileiro de Cirurgioes
|November 22, 2023
概括
COVID-19可能会引发刺激性肠综合征 (IBS) 的新病例,这是一个肠-大脑疾病. 研究表明,0.6%至11.6%的患者感染后出现IBS,其中风险因素包括女性性别和严重的COVID-19.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 精神病学是一个精神病学.
背景情况:
- 长期的COVID-19症状给医学界带来了挑战.
- 刺激性肠综合征 (IBS) 是一种常见的肠-大脑疾病,经过验证后感染发展.
- 本综述重点关注COVID-19感染后的刺激性肠综合征 (IBS).
结论:
- 感染COVID-19可能与新发性刺激性肠综合征 (IBS) 的出现有关.
- 需要进一步的研究来了解COVID-19后IBS的长期影响和临床谱.
- 强调需要在病毒感染后继续对肠-大脑轴进行调查.
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
280
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
280
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
165
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
165
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
213
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
213
01:17Drugs for Treatment of Diarrhea-Predominant IBS
183
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
183
01:17Chronic Bowel Disorders: Introduction
457
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
457
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
337
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
337